Michael A.FiferMD
Cardiology • Boston, MAProfessor of Medicine, Harvard Medical School; Director, Hypertrophic Cardiomyopathy Program, Massachusetts General Hospital
Dr. Fifer is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
55 Fruit St
Grb 8
Boston, MA 02114Phone+1 617-726-1832Fax+1 617-726-7437- Is this information wrong?
Education & Training
Brigham and Women's HospitalFellowship, Cardiovascular Disease, 1981 - 1983
Massachusetts General HospitalResidency, Internal Medicine, 1978 - 1981
Harvard Medical SchoolClass of 1978
Certifications & Licensure
MA State Medical License 1980 - 2025
FL State Medical License 2011 - 2019- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
Awards, Honors, & Recognition
- Fellow (FACC) American College of Cardiology
- Top MD Consumers Checkbook
- Super Doctor SuperDoctors.com
Clinical Trials
- Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy Start of enrollment: 2007 Feb 01
Publications & Presentations
PubMed
- Efficacy and Safety of aficamten in Symptomatic Non-Obstructive Hypertrophic Cardiomyopathy: Results From the REDWOOD-HCM Trial, Cohort 4.Ahmad Masri, Mark V Sherrid, Theodore P Abraham, Lubna Choudhury, Pablo Garcia-Pavia, Christopher M Kramer, Roberto Barriales-Villa, Anjali T Owens, Florian Rader, She...> ;Journal of Cardiac Failure. 2024 Mar 15
- Mortality After Alcohol Septal Ablation vs. Septal Myectomy in Patients With Obstructive Hypertrophic Cardiomyopathy.Risako Yasuda, Itsuki Osawa, Tadahiro Goto, Kohei Hasegawa, Michael A Fifer, Albree Tower-Rader, Muredach P Reilly, Mathew S Maurer, Yanling Zhao, Hiroo Takayama, Yuic...> ;Circulation Reports. 2024 Mar 8
- Prediction of cardiac death in patients with hypertrophic cardiomyopathy using plasma adipokine levels.Akita, K., Jung, J., Hasegawa, K., Fifer, M., Tower-Rader, A., Maurer, M., Reilly, M., Shimada, Y.> ;Nutrition, Metabolism, and Cardiovascular Diseases. 2024 Jan 18
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Massachusetts General HospitalBoston, Massachusetts
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
